---  
layout: startup_page  
title: "Vico Therapeutics"  
id: "vicotx.com"  
permalink: "/vicotherapeuticsvicotx.com01052024/"  
website: "https://www.vicotx.com"  
funding_round: "Series B"  
funding_amount: "$60M"  
investors: "Ackermans & van Haaren, Droia Ventures, EQT Life Sciences, Kurma Partners, Polaris Partners, Pureos Bioventures, Eurazeo"  
about: "Vico Therapeutics is a clinical-stage genetic medicines company developing antisense oligonucleotide (ASO) RNA modulating therapies for severe neurological diseases. Their lead product candidate, VO659, is in Phase 1/2a clinical development for spinocerebellar ataxia types 3 and 1, and Huntington's disease. Vico's research platform designs ASOs to target genetic neurological diseases."  
markets: "Biotechnology, Genetic Medicines, Neurological Diseases"  
hq: "Leiden, South Holland, Netherlands"  
founded_year: "2019"  
linkedin: "https://www.linkedin.com/company/vico-therapeutics/"  
twitter: "https://twitter.com/VicoThera"  
instagram: ""  
facebook: "https://www.facebook.com/Vico-Therapeutics-BV-116309576584596"  
crunchbase: "https://www.crunchbase.com/organization/vico-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/432829-81"  

date_display: "05-Jan-2024"  
date: "2024-01-05"

# SEO Optimization  
meta_title: "Vico Therapeutics - Series B Funding ($60M)"  
meta_description: "Vico Therapeutics, Vico Therapeutics is a clinical-stage genetic medicines company developing antisense oligonucleotide (ASO) RNA modulating therapies for severe neurolo..."  
meta_keywords: "Vico Therapeutics, Biotechnology, Genetic Medicines, Neurological Diseases, Series B funding"  
canonical_url: "https://startup.projectstartups.com/vicotherapeuticsvicotx.com01052024/"  
---